Literature DB >> 28573615

Modeling the Ebolavirus Life Cycle with Transcription and Replication-Competent Viruslike Particle Assays.

Nadine Biedenkopf1, Thomas Hoenen2.   

Abstract

Ebolaviruses are the causative agent of a severe hemorrhagic fever with high case fatality rates, for which no approved specific therapy is available. As biosafety level 4 (BSL4) agents, work with live ebolaviruses is restricted to maximum containment laboratories. Transcription and replication-competent viruslike particle (trVLP) systems are reverse genetics-based life cycle modeling systems that allow researchers to model virtually the entire ebolavirus life cycle outside of a maximum containment laboratory. These systems can be used to dissect the virus life cycle, and thus increase our understanding of virus biology, as well as for more applied uses such as the screening and development of novel antivirals, and thus represent powerful tools for work on ebolaviruses.

Entities:  

Keywords:  Ebolaviruses; Filoviruses; Life cycle modeling system; Reverse genetics; Transcription and replication-competent viruslike particle system; trVLPs

Mesh:

Substances:

Year:  2017        PMID: 28573615     DOI: 10.1007/978-1-4939-7116-9_9

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  10 in total

1.  The structure of the C-terminal domain of the nucleoprotein from the Bundibugyo strain of the Ebola virus in complex with a pan-specific synthetic Fab.

Authors:  Malwina J Radwańska; Mateusz Jaskółowski; Elena Davydova; Urszula Derewenda; Tsuyoshi Miyake; Daniel A Engel; Anthony A Kossiakoff; Zygmunt S Derewenda
Journal:  Acta Crystallogr D Struct Biol       Date:  2018-06-27       Impact factor: 7.652

2.  Ebola Virus Inclusion Body Formation and RNA Synthesis Are Controlled by a Novel Domain of Nucleoprotein Interacting with VP35.

Authors:  Tsuyoshi Miyake; Charlotte M Farley; Benjamin E Neubauer; Thomas P Beddow; Thomas Hoenen; Daniel A Engel
Journal:  J Virol       Date:  2020-07-30       Impact factor: 5.103

3.  The Integrity of the YxxL Motif of Ebola Virus VP24 Is Important for the Transport of Nucleocapsid-Like Structures and for the Regulation of Viral RNA Synthesis.

Authors:  Yuki Takamatsu; Larissa Kolesnikova; Martin Schauflinger; Takeshi Noda; Stephan Becker
Journal:  J Virol       Date:  2020-04-16       Impact factor: 5.103

4.  Role of VP30 Phosphorylation in Ebola Virus Nucleocapsid Assembly and Transport.

Authors:  Yuki Takamatsu; Tomoki Yoshikawa; Takeshi Kurosu; Shuetsu Fukushi; Noriyo Nagata; Masayuki Shimojima; Hideki Ebihara; Masayuki Saijo; Takeshi Noda
Journal:  J Virol       Date:  2022-08-22       Impact factor: 6.549

5.  Ebola virus proteins NP, VP35, and VP24 are essential and sufficient to mediate nucleocapsid transport.

Authors:  Yuki Takamatsu; Larissa Kolesnikova; Stephan Becker
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-16       Impact factor: 11.205

6.  Genome-Wide Search for Competing Endogenous RNAs Responsible for the Effects Induced by Ebola Virus Replication and Transcription Using a trVLP System.

Authors:  Zhong-Yi Wang; Zhen-Dong Guo; Jia-Ming Li; Zong-Zheng Zhao; Ying-Ying Fu; Chun-Mao Zhang; Yi Zhang; Li-Na Liu; Jun Qian; Lin-Na Liu
Journal:  Front Cell Infect Microbiol       Date:  2017-11-21       Impact factor: 5.293

7.  Inhibition of in vitro Ebola infection by anti-parasitic quinoline derivatives.

Authors:  Shawn Goyal; Beth Binnington; Stephen D S McCarthy; Didier Desmaële; Laurent Férrié; Bruno Figadère; Philippe M Loiseau; Donald R Branch
Journal:  F1000Res       Date:  2020-04-17

8.  Quantification of Ebola virus replication kinetics in vitro.

Authors:  Laura E Liao; Jonathan Carruthers; Sophie J Smither; Simon A Weller; Diane Williamson; Thomas R Laws; Isabel García-Dorival; Julian Hiscox; Benjamin P Holder; Catherine A A Beauchemin; Alan S Perelson; Martín López-García; Grant Lythe; John N Barr; Carmen Molina-París
Journal:  PLoS Comput Biol       Date:  2020-11-02       Impact factor: 4.475

9.  A Rapid Screen for Host-Encoded miRNAs with Inhibitory Effects against Ebola Virus Using a Transcription- and Replication-Competent Virus-Like Particle System.

Authors:  Zhongyi Wang; Jiaming Li; Yingying Fu; Zongzheng Zhao; Chunmao Zhang; Nan Li; Jingjing Li; Hongliang Cheng; Xiaojun Jin; Bing Lu; Zhendong Guo; Jun Qian; Linna Liu
Journal:  Int J Mol Sci       Date:  2018-05-16       Impact factor: 5.923

10.  Serine-Arginine Protein Kinase 1 Regulates Ebola Virus Transcription.

Authors:  Yuki Takamatsu; Verena Krähling; Larissa Kolesnikova; Sandro Halwe; Clemens Lier; Stefan Baumeister; Takeshi Noda; Nadine Biedenkopf; Stephan Becker
Journal:  mBio       Date:  2020-02-25       Impact factor: 7.867

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.